QNTA logo

Quanta, Inc. (QNTA) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

QNTA, $ (piyasa değeri 0) fiyatla Consumer Defensive işi olan Quanta, Inc.'i temsil ediyor. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 50/100 puan alıyor.

Son analiz: 18 Mar 2026
50/100 AI Puanı

Quanta, Inc. (QNTA) Tüketici İşletmesi Genel Bakışı

CEOArthur G. Mikaelian
Çalışanlar4
MerkezBurbank, US
Halka Arz Yılı2018

Quanta, Inc. operates in the consumer wellness sector, providing pharmaceutical-grade products, clinical evidence-based nutraceuticals, and contract research services. The company utilizes patented polarization technology in its offerings, targeting pain relief, beauty, and general wellness markets, while facing competition from established players.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 18 Mar 2026

Yatırım Tezi

Quanta, Inc. presents a high-risk, high-reward investment opportunity within the consumer wellness sector. The company's reliance on patented polarization technology and contract research services could drive growth if successfully commercialized. However, the company's negative profit margin of -1312.4% and small market capitalization of $0.00B highlight significant financial challenges. Key value drivers include successful product development and market penetration in the pain relief, beauty, and general wellness categories. Upcoming catalysts involve securing additional contract research agreements and expanding distribution channels. Potential risks include intense competition, limited financial resources, and the need for further clinical validation of its technology. Investors should carefully consider the company's financial position and execution risks before investing.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Gross Margin of 78.7% indicates strong potential for profitability if sales volume increases.
  • Negative Profit Margin of -1312.4% reflects significant operational losses and the need for improved cost management.
  • Market Cap of $0.00B signifies a micro-cap company with high growth potential but also high risk.
  • The company's Beta of 1.68 suggests higher volatility compared to the overall market.
  • Founded in 2016, Quanta is a relatively young company in the competitive consumer wellness market.

Rakipler & Benzerleri

Güçlü Yönler

  • Patented polarization technology.
  • Contract research service offerings.
  • Focus on pharmaceutical-grade products.
  • Potential for innovation in the consumer wellness market.

Zayıflıklar

  • Small company size with limited resources.
  • Negative profit margin and financial instability.
  • Limited brand recognition and market presence.
  • Reliance on a small number of employees.

Katalizörler

  • Upcoming: Potential new contract research agreements with pharmaceutical or nutraceutical companies.
  • Upcoming: Launch of new consumer wellness products utilizing patented polarization technology.
  • Ongoing: Expansion of e-commerce platform and direct-to-consumer sales.
  • Ongoing: Exploration of strategic partnerships with established distributors and retailers.

Riskler

  • Potential: Intense competition from larger, more established companies in the consumer wellness market.
  • Potential: Limited financial resources and the need for additional funding.
  • Potential: Regulatory hurdles and compliance requirements for pharmaceutical and nutraceutical products.
  • Ongoing: Negative profit margin and financial instability.
  • Ongoing: Dependence on patented polarization technology and the risk of technological obsolescence.

Büyüme Fırsatları

  • Expansion of Contract Research Services: Quanta can leverage its research and development capabilities to secure additional contract research agreements with pharmaceutical and nutraceutical companies. The global contract research organization (CRO) market is projected to reach $79.3 billion by 2027, offering significant growth potential for Quanta. Timeline: Ongoing.
  • Product Line Expansion: Quanta can introduce new products within the pain relief, beauty, and general wellness categories, leveraging its patented polarization technology. The global pain relief market is expected to reach $11.3 billion by 2028. Successful product launches can drive revenue growth and market share gains. Timeline: 1-2 years.
  • Strategic Partnerships: Quanta can form strategic partnerships with established distributors and retailers to expand its market reach and distribution channels. Collaborations with major retailers can provide access to a wider customer base and increase brand visibility. Timeline: Ongoing.
  • E-commerce Channel Development: Quanta can invest in its e-commerce platform to drive direct-to-consumer sales and improve customer engagement. The global e-commerce market is experiencing rapid growth, providing opportunities for Quanta to expand its online presence and reach new customers. Timeline: 6-12 months.
  • International Market Expansion: Quanta can explore opportunities to expand its operations into international markets, particularly in regions with growing demand for consumer wellness products. Entering new markets can diversify revenue streams and reduce reliance on the domestic market. Timeline: 2-3 years.

Fırsatlar

  • Expansion of contract research services.
  • New product development and market penetration.
  • Strategic partnerships with established distributors.
  • Growth in the consumer wellness market.

Tehditler

  • Intense competition from larger companies.
  • Regulatory hurdles and compliance requirements.
  • Economic downturn and reduced consumer spending.
  • Technological obsolescence.

Rekabet Avantajları

  • Patented Polarization Technology: Provides a unique selling proposition and potential competitive advantage.
  • Contract Research Services: Offers a diversified revenue stream and opportunities for collaboration.
  • Focus on Pharmaceutical-Grade Products: Targets a higher-margin segment of the consumer wellness market.

QNTA Hakkında

Founded in 2016 and headquartered in Burbank, California, Quanta, Inc. is an applied science company focused on the development, production, and distribution of consumer wellness products. The company operates within the household and personal products industry, offering a range of pharmaceutical, nutraceutical, topical relief, and cosmetic products. Quanta's business model encompasses contract research services, including research, development, and production of pharmaceutical-grade products, as well as clinical evidence-based nutraceuticals utilizing patented polarization technology. Quanta manufactures and distributes consumer wellness products targeting pain relief, beauty, and general wellness. The company's patented polarization technology is a key differentiator in its nutraceutical offerings. While relatively young, Quanta seeks to establish itself through innovation and contract research services, aiming to capture market share in the competitive consumer wellness landscape. The company's small size, with only 4 employees, indicates an early stage of development and a focus on leveraging its technology and research capabilities.

Ne Yaparlar

  • Develops pharmaceutical-grade products.
  • Creates clinical evidence-based nutraceuticals.
  • Manufactures topical relief products.
  • Produces cosmetic products.
  • Offers contract research services to other companies.
  • Utilizes patented polarization technology in its products.
  • Distributes consumer wellness products.

İş Modeli

  • Generates revenue through the sale of pharmaceutical, nutraceutical, topical relief, and cosmetic products.
  • Earns income from contract research services provided to other companies.
  • Utilizes patented polarization technology to create differentiated products.
  • Focuses on the consumer wellness market.

Sektör Bağlamı

Quanta, Inc. operates in the competitive household and personal products industry, which is characterized by established players and evolving consumer preferences. The global wellness market is experiencing growth, driven by increased health awareness and demand for natural and innovative products. Quanta's focus on pharmaceutical-grade products and patented polarization technology positions it within the higher-margin segments of the market. However, the company faces competition from larger, more established companies with greater resources and brand recognition. Key trends include personalized wellness solutions and e-commerce distribution.

Kilit Müşteriler

  • Consumers seeking pain relief products.
  • Individuals interested in beauty and cosmetic products.
  • Customers looking for general wellness solutions.
  • Pharmaceutical and nutraceutical companies seeking contract research services.
AI Güveni: 67% Güncellendi: 18 Mar 2026

Finansallar

Grafik & Bilgi

Quanta, Inc. (QNTA) hisse senedi fiyatı: Price data unavailable

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

QNTA için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

QNTA için Wall Street fiyat hedefi analizi.

MoonshotScore

50/100

Bu puan ne anlama geliyor?

MoonshotScore, QNTA'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Arthur G. Mikaelian

CEO

Arthur G. Mikaelian serves as the CEO of Quanta, Inc., leading a small team of 4 employees. Information regarding his detailed career history and educational background is not available in the provided data. However, as CEO, he is responsible for the overall strategic direction and operational management of the company, focusing on the development and commercialization of Quanta's pharmaceutical, nutraceutical, and cosmetic products.

Sicil: Due to the limited information available, Arthur G. Mikaelian's track record at Quanta, Inc. cannot be comprehensively assessed. However, as the CEO since 2016, he has overseen the company's development and launch of products utilizing patented polarization technology. Further information is needed to evaluate his specific achievements and strategic decisions.

QNTA OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Quanta, Inc. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial information available and may be subject to greater regulatory scrutiny. Trading on the OTC Other tier carries higher risks compared to exchanges like the NYSE or NASDAQ due to less stringent listing standards and potentially lower liquidity.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Liquidity for QNTA is likely very limited due to its OTC Other listing and small market capitalization. Bid-ask spreads are expected to be wide, and it may be difficult to buy or sell large quantities of shares without significantly impacting the price. Investors should exercise caution when trading QNTA due to the potential for price volatility and illiquidity.
OTC Risk Faktörleri:
  • Limited financial disclosure and transparency.
  • Potential for price manipulation and fraud.
  • Higher risk of delisting or trading suspension.
  • Lower liquidity and wider bid-ask spreads.
  • Limited regulatory oversight.
Durum Tespiti Kontrol Listesi:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's intellectual property and technology.
  • Review the company's legal and regulatory compliance.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before making any investment decisions.
Meşruiyet Sinyalleri:
  • Patented polarization technology.
  • Contract research service offerings.
  • Focus on pharmaceutical-grade products.
  • Headquartered in Burbank, California.

QNTA Hakkında Sıkça Sorulan Sorular

QNTA için değerlendirilmesi gereken temel faktörler nelerdir?

Quanta, Inc. (QNTA) şu anda yapay zeka skoru 50/100, orta puanı gösteriyor. Temel güçlü yan: Patented polarization technology.. İzlenmesi gereken birincil risk: Potential: Intense competition from larger, more established companies in the consumer wellness market.. Bu bir finansal tavsiye değildir.

QNTA MoonshotScore'u nedir?

QNTA şu anda MoonshotScore'da 50/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

QNTA verileri ne sıklıkla güncellenir?

QNTA fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler QNTA hakkında ne diyor?

QNTA için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

QNTA'a yatırım yapmanın riskleri nelerdir?

QNTA için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Intense competition from larger, more established companies in the consumer wellness market.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

QNTA'ın P/E oranı nedir?

QNTA için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için QNTA'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

QNTA aşırı değerli mi, yoksa düşük değerli mi?

Quanta, Inc. (QNTA)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

QNTA'ın temettü verimi nedir?

Quanta, Inc. (QNTA) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Limited information available on the company's financials and operations.
  • OTC listing and small market capitalization increase investment risk.
  • Lack of analyst coverage and consensus.
Veri Kaynakları

Popüler Hisseler